Summary
This Form 8-K/A filing from Thermo Fisher Scientific Inc. (formerly Thermo Electron Corporation) serves as an amendment to a previous 8-K filing from May 12, 2005. The primary purpose of this amendment is to provide the required historical financial statements for the acquired Kendro Laboratory Products division of SPX Corporation, along with pro forma financial information. This information is crucial for investors to understand the financial impact of the Kendro acquisition on Thermo Fisher Scientific's combined entity. The filing includes detailed financial statements of Kendro for periods ending in early 2005 and late 2004, alongside pro forma statements reflecting the combined entity's financial position and performance as if the acquisition had occurred earlier. Investors should review these financials to assess the revenue, profitability, and balance sheet implications of this strategic acquisition.
Key Highlights
- 1Amendment to previous 8-K filing to provide supplemental financial information regarding the acquisition of Kendro Laboratory Products.
- 2Inclusion of historical financial statements for the acquired Kendro business as of March 31, 2005, and for the periods ended March 31, 2005, March 31, 2004, and December 31, 2004.
- 3Presentation of unaudited pro forma condensed combined financial statements reflecting the combined entity post-acquisition.
- 4Financial statements include Income Statements, Balance Sheets, and Cash Flow Statements for Kendro.
- 5Pro forma financial information includes a balance sheet as of April 2, 2005, and income statements for the three months ended April 2, 2005, and the year ended December 31, 2004.
- 6Exhibits include the consent of Deloitte & Touche LLP, the Credit Agreement for the acquisition, an Amendment to the Purchase Agreement, and a press release announcing the acquisition closing.